Yoshida, Kenji
Kyoto University · Sumitomo Dainippon Pharma (Japan) · Center for iPS Cell Research and Application, Kyoto University
2 papers on CoChatORCID 0009-0003-4186-0437
Most cited papers
- Verified
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
Doi, D., Magotani, H., Kikuchi, T., Ikeda, M., Hiramatsu, S., Yoshida, K., Amano, N., Nomura, M., Umekage, M., Morizane, A., et al. (2020) · Nature Communications
Pluripotent Stem Cells ResearchParkinson's Disease Mechanisms and Treatments
Cited by 350
- Verified
Estrogen-dependent proteolytic cleavage of semaphorin 4D and plexin-B1 enhances semaphorin 4D-induced apoptosis during postnatal vaginal remodeling in pubescent mice
Ito, T., Bai, T., Tanaka, T., Yoshida, K., Ueyama, T., Miyajima, M., Negishi, T., Kawasaki, T., Takamatsu, H., Kikutani, H., et al. (2014) · PLoS ONE
Axon Guidance and Neuronal SignalingSexual Differentiation and Disorders
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free